| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.5 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.5 |